ArticleFrontiers in neuroscience2024
A recurrent YOLOv8-based framework for event-based object detection.
Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- PMRVT: Parallel Attention Multilayer Perceptron Recurrent Vision Transformer for Object Detection with Event Cameras.Sensors (Basel, Switzerland) · 2025Article
- Chimera: a block-based neural architecture search framework for event-based object detection.Frontiers in artificial intelligence · 2025Article
- Efficient and real-time perception: a survey on end-to-end event-based object detection in autonomous driving.Frontiers in robotics and AI · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Object detection plays a crucial role in various cutting-edge applications, such as autonomous vehicles and advanced robotics systems, primarily relying on conventional frame-based RGB sensors. However, these sensors face challenges such as motion blur and poor performance under extreme lighting conditions. Novel event-based cameras, inspired by biological vision systems, offer a promising solution with superior performance in fast-motion and challenging lighting environments while consuming less power. This work explores the integration of event-based cameras with advanced object detection frameworks, introducing Recurrent YOLOv8 (ReYOLOV8), a refined object detection framework that enhances a leading frame-based YOLO detection system with spatiotemporal modeling capabilities by adding recurrency. ReYOLOv8 incorporates a low-latency, memory-efficient method for encoding event data called Volume of Ternary Event Images (VTEI) and introduces a novel data augmentation technique based on Random Polarity Suppression (RPS) optimized for event-based sensors and tailored to leverage the unique attributes of event data. The framework was evaluated using two comprehensive event-based datasets Prophesee's Generation 1 (GEN1) and Person Detection for Robotics (PEDRo). On the GEN1 dataset, ReYOLOv8 achieved mAP improvements of 5%, 2.8%, and 2.5% across nano, small, and medium scales, respectively, while reducing trainable parameters by 4.43% on average and maintaining real-time processing speeds between 9.2 ms and 15.5 ms. For the PEDRo dataset, ReYOLOv8 demonstrated mAP improvements ranging from 9% to 18%, with models reduced in size by factors of 14.5 × and 3.8 × and an average speed improvement of 1.67 × . The results demonstrate the significant potential of bio-inspired event-based vision sensors when combined with advanced object detection frameworks. In particular, the ReYOLOv8 system effectively bridges the gap between biological principles of vision and artificial intelligence, enabling robust and efficient visual processing in dynamic and complex environments. The codes are available on GitHub at the following link https://github.com/silvada95/ReYOLOv8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.